Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gratzke

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Der Urologe. Ausg. A|August 12, 2009
[Urinary incontinence after radical prostatectomy]R M Bauer, M E Mayer, C Gratzke, et al.
Surgical Oncology|March 8, 2025
Metastasis directed therapy in recurrent renal cell carcinoma - Retrospective analysis of a ten-year experienceR Himmelsbach, J Stigler, M Weishaar, et al.
World Journal of Urology|August 2, 2024
Real-world experience with the new pulsed solid-state Thulium: YAG laser (Thulio) for endoscopic enucleation of the prostateMaximilian Ferry von Bargen, M Glienke, S Tonyali, et al.
MMW Fortschritte Der Medizin|June 17, 2009
[Treatment of female urinary incontinence]R M Bauer, C Gozzi, M Mayer, et al.
Der Urologe. Ausg. A|November 10, 2012
[New treatment strategies for male lower urinary tract symptoms]L F Arenas da Silva, M Schönthaler, F Cruz, et al.
Der Urologe. Ausg. A|August 28, 2019
[Treatment of benign prostatic hyperplasia in geriatric patients-use and limitations of existing guidelines]D S Schoeb, B Wullich, D Dürschmied, et al.
European Journal of Medical Research|May 11, 2010
Minimizing complications during retropubic radical prostatectomy - Is ureteral stenting necessary?B Schlenker, C Gratzke, M Seitz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 2, 2016
Perioperative and oncologic outcomes of robot-assisted vs. open radical cystectomy in bladder cancer patients: A comparison of two high-volume referral centersG Gandaglia, A Karl, G Novara, et al.
Der Urologe. Ausg. A|December 17, 2020
[Empowerment for our patients : Innovation in everyday urology]J Huber, P Karschuck, C Groeben, et al.
Neurourology and Urodynamics|September 19, 2014
Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitorC Füllhase, M Hennenberg, P Sandner, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Der Urologe. Ausg. A|August 12, 2009
[Urinary incontinence after radical prostatectomy]R M Bauer, M E Mayer, C Gratzke, et al.
Surgical Oncology|March 8, 2025
Metastasis directed therapy in recurrent renal cell carcinoma - Retrospective analysis of a ten-year experienceR Himmelsbach, J Stigler, M Weishaar, et al.
World Journal of Urology|August 2, 2024
Real-world experience with the new pulsed solid-state Thulium: YAG laser (Thulio) for endoscopic enucleation of the prostateMaximilian Ferry von Bargen, M Glienke, S Tonyali, et al.
MMW Fortschritte Der Medizin|June 17, 2009
[Treatment of female urinary incontinence]R M Bauer, C Gozzi, M Mayer, et al.
Der Urologe. Ausg. A|November 10, 2012
[New treatment strategies for male lower urinary tract symptoms]L F Arenas da Silva, M Schönthaler, F Cruz, et al.
Der Urologe. Ausg. A|August 28, 2019
[Treatment of benign prostatic hyperplasia in geriatric patients-use and limitations of existing guidelines]D S Schoeb, B Wullich, D Dürschmied, et al.
European Journal of Medical Research|May 11, 2010
Minimizing complications during retropubic radical prostatectomy - Is ureteral stenting necessary?B Schlenker, C Gratzke, M Seitz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 2, 2016
Perioperative and oncologic outcomes of robot-assisted vs. open radical cystectomy in bladder cancer patients: A comparison of two high-volume referral centersG Gandaglia, A Karl, G Novara, et al.
Der Urologe. Ausg. A|December 17, 2020
[Empowerment for our patients : Innovation in everyday urology]J Huber, P Karschuck, C Groeben, et al.
Neurourology and Urodynamics|September 19, 2014
Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitorC Füllhase, M Hennenberg, P Sandner, et al.
Pageof 10